Jaguar Health, Inc.
JAGX
$12.98
$1.119.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 52.57% | 10.49% | 1.68% | 19.22% | -29.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.57% | 10.49% | 1.68% | 19.22% | -29.45% |
| Cost of Revenue | -18.92% | 5.25% | -13.03% | 24.64% | 38.79% |
| Gross Profit | 83.01% | 11.66% | 4.99% | 18.07% | -41.66% |
| SG&A Expenses | 23.22% | 15.60% | -2.86% | -13.04% | 12.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.98% | -10.60% | -7.98% | -10.59% | -0.63% |
| Operating Income | -13.51% | 17.36% | 11.17% | 16.56% | -14.32% |
| Income Before Tax | -9.94% | -26.78% | 21.67% | 24.43% | -13.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.94% | -26.78% | 21.67% | 24.43% | -13.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 125.90% | 32.54% | -3.55% | -27.18% | -78.65% |
| Net Income | -8.18% | -26.69% | 21.88% | 24.39% | -20.96% |
| EBIT | -13.51% | 17.36% | 11.17% | 16.56% | -14.32% |
| EBITDA | -14.89% | 18.05% | 11.17% | 17.42% | -15.50% |
| EPS Basic | 92.60% | 95.33% | 90.23% | -- | -- |
| Normalized Basic EPS | 92.36% | 96.84% | 90.24% | -- | -- |
| EPS Diluted | 92.60% | 95.33% | 90.23% | -- | -- |
| Normalized Diluted EPS | 92.36% | 96.84% | 90.24% | -- | -- |
| Average Basic Shares Outstanding | 1,361.04% | 2,615.94% | 696.61% | -- | -- |
| Average Diluted Shares Outstanding | 1,361.04% | 2,615.94% | 696.61% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |